SIRT1 and metabolic dysfunction-associated steatotic liver disease: Sirt1 also regulates adenosine 5’-monophosphate-activated protein kinase (AMPK) phosphorylation [48,49], which has been shown to reduce lipid production, enhance fatty acid oxidation, and ultimately inhibit the development of NAFLD when it is activated [50].